Elevated factor VII as a risk factor for recurrent fetal loss: Relationship to factor VII gene polymorphisms

Thrombosis and Haemostasis

Volumn 93, Issue 6, 2005, Pages 1089-1094

  Miller, Connie H ^a   De Staercke, Christine ^a   Benson, Jane ^a   Hooper, W Craig ^a   Dilley, Anne ^a,e   Evatt, Bruce L ^a   Benito, Carlos ^b   Patterson Barnett, Anne ^c   Eller, Daniel ^c   Philipp, Claire S ^d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b SAINT PETER S UNIVERSITY HOSPITAL   (United States)

^c Northside Women's Specialists   (United States)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Factor VII; Factor VII polymorphisms; Fetal loss; Recurrent fetal loss

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; DNA;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA DETERMINATION; FEMALE; FETUS WASTAGE; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RECURRENT DISEASE; RISK FACTOR; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY;

ABORTION, HABITUAL; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA; FACTOR VII; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INFANT, NEWBORN; ODDS RATIO; POLYMORPHISM, GENETIC; PREGNANCY; RISK FACTORS;

EID: 20444435098     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-09-0583     Document Type: Article

References (39)

1. Brenner B. Inherited thrombophilia and pregnancy loss. Baillieres Best Pract Res Clin Haematol 2003; 16: 311-20.
2. Rey E, Kahn SR, David M et al. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003; 361: 901-8.
3. Preston FE, Rosendaal FR, Walker ID et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996; 348: 913-6.
4. Lanir N, Aharon A, Brenner B. Haemostatic mechanisms in human placenta. Baillieres Best Pract Res Clin Haematol 2003; 16: 183-95.
5. Rao LV, Rapaport SI. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. Proc Natl Acad Sci U S A 1988; 85: 6687-91.
6. Rapaport SI, Rao LV. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb 1992; 12: 1111-21.
7. Meade TW, Mellows S, Brozovic M et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-7.
8. Junker R, Heinrich J, Schulte H et al. Coagulation factor VII and the risk of coronary heart disease in healthy men. Arterioscler Thromb 1997; 17: 1539-44.
9. Redondo M, Watzke HH, Stucki B et al. Coagulation factors II, V, VII, and X, prothrombin gene 20210G>A transition, and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction. Arterioscler Thromb Vasc Biol 1999; 19: 1020-5.
10. Folsom AR, Wu KK, Rosamond WD et al. Prospective study of hemostatic factors and incidence of coronary heart disease: the Arthritis Risk in Communities (ARIC) Study. Circulation 1997; 96: 1102-8.
11. Smith FB, Lee AJ, Fowkes FGR et al. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 1997; 17: 3321-5.
12. Green F, Kelleher C, Wilkes H et al. A common genetic polymorphism associated with lower factor VII levels in healthy individuals. Arterioscler Thromb 1991; 11: 540-6.
13. Marchetti G, Patracchini P, Papaschini M et al. A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide. Hum Genet 1993; 90: 575-6.
14. Van't Hooft FM, Silveira A, Tornvall P et al. Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration. Blood 1999; 93: 3432-41.
15. Peyvandi F, Mannucci PM, Bucciarelli P et al. A novel polymorphism in intron 1a of the human factor VII gene (G73A): a study of a healthy Italian population and of 190 young survivors of myocardial infarction. Br J Haematol 2000; 108: 247-53.
16. Pinotti M, Tosco R, Girelli D et al. Modulation of factor VII levels by intron 7 polymorphisms: population and in vitro studies. Blood 2000; 95: 3423-8.
17. Lane A, Green F, Scarabin PY et al. Factor VII Arg/Gln polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study. Atherosclerosis 1996; 119: 119-27.
18. Wang XL, Wang J, McCredie RM et al. Polymorphisms of factor V, factor VII, and fibrinogen genes: relevance to severity of coronary artery disease. Arterioscler Thromb Biol 1997; 17: 246-51.
19. Feng DL, Tofler GH, Larson MG et al. Factor VII gene polymorphism, factor VII levels, and prevalent cardiovascular disease: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2000; 20: 593-600.
20. Carew JA, Basso F, Miller GJ et al. A functional haplotype in the 5′ flanking region of the factor VII gene is associated with an increased risk of coronary heart disease. J Thromb Haemost 2003; 1: 2179-85.
21. Koster T, Rosendaal FR, Reitsma PH et al. Factor VII and fibrinogen levels as risk factors for venous thrombosis - A case-control study of plasma levels and DNA polymorphisms - The Leiden Thrombophilia Study (LETS). Thromb Haemst 1994; 71: 719-22.
22. Austin H, Hooper WC, Lally C et al. Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans. J Clin Epidemiol 2000; 53: 997-1001.
23. Dalaker K. Clotting factor VII during pregnancy, delivery and puerperium. Brit J Obstet Gynaecol 1986; 93: 17-21.
24. De Moerloose P, Amiral J, Vissac AM et al. Longitudinal study on activated factors XII and VII levels during normal pregnancy. Br J Haematol 1998; 100: 40-4.
25. Wright D, Poller L, Thomson JM et al. A longitudinal study of the factor VII rise during pregnancy. Thromb Haemost 1998; 79: 328-30.
26. Scarabin PY, Bonithon-Kopp C, Bara L et al. Is factor VII activation in pregnant women relevant to foetal growth retardation? Thromb Res 1987; 45: 845-50.
27. Dilley A, Benito C, Hooper WC et al. Mutations in the factor V, prothrombin and MTHFR genes are not risk factors for recurrent fetal loss. J Matern Fet Neonat Med 2002; 11: 176-82.
28. O'Hara PJ, Grant FJ, Haldeman BA et al. Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proc Natl Acad Sci USA 1987; 84: 5158-62.
29. Erdmann D, Heim J. Orphan nuclear receptor HNF-4 binds to the human coagulation factor VII promoter. J Biol Chem 1995; 270: 22988-96.
30. Rothman KJ, Greenland S. Modern Epidemiology. Philadelphia. Lippincott-Raven Publishers; 1998.
31. Scarabin PY, Vissac AM, Kirzin JM et al. Population correlates of coagulation factor VII: importance of age, sex, and menopausal status as determinants of activated factor VII. Arterioscler Thromb Vasc Biol 1996; 16: 1170-6.
32. Bloemenkamp KWM, de Maat MPM, Dersjant-Roorda MC et al. Genetic polymorphisms modify the response of factor VII to oral contraceptive use: an example of gene-environment interaction. Vasc Pharmacol 2002; 39: 121-6.
33. Middeldorp S, Meijers CJM, van den Ende AE et al. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a crossover study. Thromb Haemost 2000; 84: 4-8.
34. Hunault M, Arbini AA, Lopaciuk S et al. The Arg353Gln polymorphism reduces the level of coagulation factor VII: in vivo and in vitro studies. Arterioscler Thromb Vasc Biol 1997; 17: 2825-9.
35. Mann KG. Factor VII assays, plasma triglyceride levels, and cardiovascular disease risk. Arteriosclerosis 1989; 9: 783.
36. Miller GJ, Stirling Y, Esnouf MP et al. Factor VII-deficiency substrate plasma depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study. Thromb Haemost 1994; 71: 38-48.
37. Morrissey JH, Macik BG, Neuenschwander PF et al. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81: 734-44.
38. Torry DS, Labarrere CA, McIntyre JA. Uteroplacental vascular involvement in recurrent spontaneous abortion. Curr Opinion Obstet Gynecol 1998; 10: 379-82.
39. Salafia CM. Placental pathology of fetal growth restriction. Clin Obstet Gynecol 1997; 40: 740-9.